SHANGHAI and CAMBRIDGE, Mass, Nov. 14, 2026 /PRNewswire/ -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), an innovation-driven, global biopharma company, today announced that five of its commercial medicines in China have been included in the country's 2026 National Reimbursement Drug List (NRDL). The update includes two first-time listings,...
SHANGHAI, Dec. 17, 2025 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing,...
TAIPEI, Dec. 17, 2025 /PRNewswire/ -- This year, 2025 Camping Asia, a collaboration among the Taipei Performing Arts Center, the Centre National de la Danse...
HONG KONG, Dec. 17, 2025 /PRNewswire/ -- Tencent Cloud, the cloud business of global technology company Tencent, today announced its strategic partnership with Bitkub Group,...
TOKYO, Dec. 17, 2025 /PRNewswire/ -- Tokyo Electric Power Company Holdings, Inc. (hereinafter "TEPCO HD") is pleased to announce that, on December 4, 2025, a...
Highlighting advances in vascular aging research and microalgae-based Omega-3 innovation SINGAPORE, Dec. 17, 2025 /PRNewswire/ -- The 5th World Biological Science and Technology Conference...
